← Evidence map

ArticleBMJ open2015

Correction. Health Canada's use of its priority review process for new drugs: a cohort study.

J LexchinPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 26384720